Nonprofit, nonpartisan journalism. Supported by readers.

Donate
Topics

Paulsen teases new legislation after FDA testimony

The FDA’s slow approval procedures put American businesses at risk, Paulsen said, adding he plans to propose a bill to change the process.

Article continues after advertisement